---
title: "Investors offer backing for developer of transcatheter mitral chord repair technology"
date: "2024-01-02T15:31:02.000Z"
publishedDate: "2 janvier 2024"
summary: "Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, USA, has announced that it has closed on US$13M in fresh capital (US$42M to-date). CardioMech received financial support from existing and new investors, including a non-disclosed strategic investor."
importance: ""
sourceUrl: "https://cardiovascularnews.com/investors-offer-backing-for-developer-of-transcatheter-mitral-chord-repair-technology/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-01-02-investors-offer-backing-for-developer-of-transcatheter-mitral-chord-repair-technology"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Nicolai_BAW.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/investors-offer-backing-for-developer-of-transcatheter-mitral-chord-repair-technology/"
---

![Investors offer backing for developer of transcatheter mitral chord repair technology](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Nicolai_BAW.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/investors-offer-backing-for-developer-of-transcatheter-mitral-chord-repair-technology/*

## L’essentiel

Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, USA, has announced that it has closed on US$13M in fresh capital (US$42M to-date). CardioMech received financial support from existing and new investors, including a non-disclosed strategic investor.

## Lien source

https://cardiovascularnews.com/investors-offer-backing-for-developer-of-transcatheter-mitral-chord-repair-technology/
